BIMCO Search Results

Results for:Smuggling

Showing 31 - 40 of 82

Filter by area
Filter by location
Filter by content

Prevention of wildlife smuggling by sea

31 July 2017

As one of the Buckingham Palace Declaration Signatories, BIMCO is keen to share the United for Wildlife Taskforce Alerts. These are advisories for issues of high concern related to wildlife trafficking and the transport sector, and are a core output of the Taskforce Information Sharing System.  

Prevention of wildlife smuggling by sea

31 July 2017

As one of the Buckingham Palace Declaration Signatories, BIMCO is keen to share the United for Wildlife Taskforce Alerts. These are advisories for issues of high concern related to wildlife trafficking and the transport sector, and are a core output of the Taskforce Information Sharing System.  

ROPAXTIME

17 October 2016

ROPAXTIME is a standard time charter party for the RoPax trade. It can be amended to be used for RoRo ships as well. The charter party contains the latest standard time charter clauses and includes detailed provisions covering trade specific issues such as hotel, restaurant and passenger related issues. The latest edition of this contract is ROPAXTIME, issued in 2015. Copyright in ROPAXTIME is held by BIMCO.

LINERTIME 2015

17 October 2016

The LINERTIME is a deep sea time charter party. Originally published in 1968 and revised in 1974 and 2015. The 2015 revision was a technical update where the latest editions of BIMCO’s core clauses replaced the earlier versions of the same. The latest edition of this contract is LINERTIME 2015. Copyright in LINERTIME 2015 is held by BIMCO.

What are Customs Co-operation Agreements (CCAs)?

17 October 2013

For the benefit of its members, BIMCO has made a series of agreements with 15 national customs authorities (Belgium, Canada, Cyprus, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, Norway, Sweden, the United Kingdom and the United States)- Customs Co-operation Agreements (CCAs)- as a means of mitigating delays and costs resulting from the discovery of drugs aboard a member vessel.